Form 4 for EWTX Edgewise Therapeutics, Inc.
Accepted 2026-01-05 00:00:00 ET · period of report 2026-01-02 · accession 0001655016-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-05 | 2026-01-02 | EWTX | Fox Jonathan C | Dir | A - Grant | $0.00 | +473 | 24.2K | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | A | A | 473 | $0.00 | 24,175 | D | — | — |